42:I[58016,["/_next/static/chunks/b5ea50e123aa84a6.js","/_next/static/chunks/050761d0d0bdc5d8.js","/_next/static/chunks/de880ec5a0241b38.js","/_next/static/chunks/48003610e91209eb.js","/_next/static/chunks/15a1b1fbd3cf7d4a.js","/_next/static/chunks/81ce7bf5f20dbd5a.js","/_next/static/chunks/86498082dde169e6.js","/_next/static/chunks/903c358828afe0bc.js","/_next/static/chunks/f63fb02bc4156bfb.js","/_next/static/chunks/88bed98e5cd5e639.js"],"ProcessEpisodeButton"] 44:I[185,["/_next/static/chunks/b5ea50e123aa84a6.js","/_next/static/chunks/050761d0d0bdc5d8.js","/_next/static/chunks/de880ec5a0241b38.js","/_next/static/chunks/48003610e91209eb.js","/_next/static/chunks/15a1b1fbd3cf7d4a.js","/_next/static/chunks/81ce7bf5f20dbd5a.js","/_next/static/chunks/86498082dde169e6.js","/_next/static/chunks/903c358828afe0bc.js","/_next/static/chunks/f63fb02bc4156bfb.js","/_next/static/chunks/88bed98e5cd5e639.js"],"SendEmailButton"] 45:I[45269,["/_next/static/chunks/b5ea50e123aa84a6.js","/_next/static/chunks/050761d0d0bdc5d8.js","/_next/static/chunks/de880ec5a0241b38.js","/_next/static/chunks/48003610e91209eb.js","/_next/static/chunks/15a1b1fbd3cf7d4a.js","/_next/static/chunks/81ce7bf5f20dbd5a.js","/_next/static/chunks/86498082dde169e6.js","/_next/static/chunks/903c358828afe0bc.js","/_next/static/chunks/f63fb02bc4156bfb.js","/_next/static/chunks/88bed98e5cd5e639.js"],"SignupCTA"] 47:I[56939,["/_next/static/chunks/b5ea50e123aa84a6.js","/_next/static/chunks/050761d0d0bdc5d8.js","/_next/static/chunks/de880ec5a0241b38.js","/_next/static/chunks/48003610e91209eb.js","/_next/static/chunks/15a1b1fbd3cf7d4a.js","/_next/static/chunks/81ce7bf5f20dbd5a.js","/_next/static/chunks/86498082dde169e6.js","/_next/static/chunks/903c358828afe0bc.js","/_next/static/chunks/f63fb02bc4156bfb.js","/_next/static/chunks/88bed98e5cd5e639.js"],"EpisodeTranscript"] 3c:["$","div",null,{"className":"flex flex-col gap-2 text-sm text-muted-foreground","children":[["$","span",null,{"className":"inline-flex items-center gap-2 bg-secondary/50 px-3 py-1 rounded-full","children":[["$","svg",null,{"className":"w-4 h-4","fill":"none","stroke":"currentColor","viewBox":"0 0 24 24","children":["$","path",null,{"strokeLinecap":"round","strokeLinejoin":"round","strokeWidth":2,"d":"M8 7V3m8 4V3m-9 8h10M5 21h14a2 2 0 002-2V7a2 2 0 00-2-2H5a2 2 0 00-2 2v12a2 2 0 002 2z"}]}],["$","time",null,{"dateTime":"2026-04-01T09:00:00.000Z","children":"Wed Apr 01 2026"}]]}],null]}] 43:T4ef,

What if getting breakthrough devices to the right patients wasn't a guessing game — but a data-driven science?

In this episode of Med Tech Gurus, we sit down with Mike Monovoukas, CEO and Co-Founder of AcuityMD, one of the fastest-growing platforms in MedTech. Mike shares how his team is turning mountains of messy healthcare data into clear, actionable insights — helping innovators pinpoint the right physicians, facilities, and patient populations, and transforming how devices reach the people who need them most.

We explore how AcuityMD is powering precision targeting through AI, why democratizing market intelligence helps level the playing field for new entrants, and how smarter commercialization can unlock access for underserved communities — including their work helping EPI bring the Alpha-Stim device to veterans struggling with pain, insomnia, and anxiety.

From designing platforms built specifically for MedTech, to making complex data simple for frontline sales teams, to reshaping how companies scale, Mike delivers a masterclass in building for the future of commercialization — where evidence, empathy, and AI come together.

From Data to Decisions: Powering Growth in MedTech